Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $343.85, but opened at $319.37. Bio-Rad Laboratories shares last traded at $319.37, with a volume of 256 shares changing hands.

Bio-Rad Laboratories Stock Performance

The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The firm has a 50-day moving average price of $338.36 and a two-hundred day moving average price of $332.90. The firm has a market cap of $8.74 billion, a PE ratio of -11.42 and a beta of 0.73.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.90 earnings per share for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.